-
1
-
-
77249137912
-
Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: Preliminary studies in Padova and Montpellier
-
Bruttomesso D, Farret A, Costa S, et al. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier. J Diabetes Sci Technol. 2009;3:1014-1021.
-
(2009)
J Diabetes Sci Technol
, vol.3
, pp. 1014-1021
-
-
Bruttomesso, D.1
Farret, A.2
Costa, S.3
-
2
-
-
79953021776
-
Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: Summary of the results
-
Kovatchev B, Cobelli C, Renard E, et al. Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results. J Diabetes Sci Technol. 2010;4:1374-1381.
-
(2011)
J Diabetes Sci Technol
, vol.4
, pp. 1374-1381
-
-
Kovatchev, B.1
Cobelli, C.2
Renard, E.3
-
3
-
-
84874368884
-
Nocturnal glucose control with an artificial pancreas at a diabetes camp
-
Phillip M, Battelino T, Atlas E, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med. 2013;368:824-833.
-
(2013)
N Engl J Med
, vol.368
, pp. 824-833
-
-
Phillip, M.1
Battelino, T.2
Atlas, E.3
-
4
-
-
33645051466
-
Continuous glucose monitoring and closed-loop systems
-
Hovorka R. Continuous glucose monitoring and closed-loop systems. Diabetes Med. 2006;23:1-12.
-
(2006)
Diabetes Med
, vol.23
, pp. 1-12
-
-
Hovorka, R.1
-
5
-
-
48649083317
-
Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas
-
Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care. 2008;31:934-939.
-
(2008)
Diabetes Care
, vol.31
, pp. 934-939
-
-
Weinzimer, S.A.1
Steil, G.M.2
Swan, K.L.3
Dziura, J.4
Kurtz, N.5
Tamborlane, W.V.6
-
6
-
-
77249175519
-
Overnight closedloop insulin delivery with model predictive control: Assessment of hypoglycemia and hyperglycemia risk using simulation studies
-
Wilinska ME, Budiman ES, Taub MB, et al. Overnight closedloop insulin delivery with model predictive control: Assessment of hypoglycemia and hyperglycemia risk using simulation studies. J Diabetes Sci Technol. 2009;3:1109-1120.
-
(2009)
J Diabetes Sci Technol
, vol.3
, pp. 1109-1120
-
-
Wilinska, M.E.1
Budiman, E.S.2
Taub, M.B.3
-
7
-
-
15944409169
-
The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes
-
Heptulla RA, Rodriguez LM, Bomgaars L, Haymond MW. The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes. Diabetes. 2005;54:1100-1107.
-
(2005)
Diabetes
, vol.54
, pp. 1100-1107
-
-
Heptulla, R.A.1
Rodriguez, L.M.2
Bomgaars, L.3
Haymond, M.W.4
-
8
-
-
69249228579
-
Pramlintide lowered glucose excursions and was well-Tolerated in adolescents with type 1 diabetes: Results from a randomized, single-blind, placebo-controlled, crossover study
-
Chase HP, Lutz K, Pencek R, Zhang B, Porter L. Pramlintide lowered glucose excursions and was well-Tolerated in adolescents with type 1 diabetes: results from a randomized, single-blind, placebo-controlled, crossover study. J Pediatr. 2009;155:369-373.
-
(2009)
J Pediatr
, vol.155
, pp. 369-373
-
-
Chase, H.P.1
Lutz, K.2
Pencek, R.3
Zhang, B.4
Porter, L.5
-
9
-
-
77956074558
-
The role of adjunctive exenatide therapy in pediatric type 1 diabetes
-
Raman VS, Mason KJ, Rodriguez LM, et al. The role of adjunctive exenatide therapy in pediatric type 1 diabetes. Diabetes Care. 2010;33:1294-1296.
-
(2011)
Diabetes Care
, vol.33
, pp. 1294-1296
-
-
Raman, V.S.1
Mason, K.J.2
Rodriguez, L.M.3
-
10
-
-
84869090428
-
Effect of insulin feedback on closed-loop glucose control: A crossover study
-
Ruiz JL, Sherr JL, Cengiz E, et al. Effect of insulin feedback on closed-loop glucose control: A crossover study. J Diabetes Sci Technol. 2012;6:1123-1130.
-
(2012)
J Diabetes Sci Technol
, vol.6
, pp. 1123-1130
-
-
Ruiz, J.L.1
Sherr, J.L.2
Cengiz, E.3
-
11
-
-
66149084084
-
Twenty-four-hour simultaneous subcutaneous Basal-bolus administration of insulin and amylin in adolescents with type 1 diabetes decreases postprandial hyperglycemia
-
Heptulla RA, Rodriguez LM, Mason KJ, Haymond MW. Twenty-four-hour simultaneous subcutaneous Basal-bolus administration of insulin and amylin in adolescents with type 1 diabetes decreases postprandial hyperglycemia. J Clin Endocrinol Metab. 2009;94:1608-1611.
-
(2009)
J Clin Endocrinol Metab
, vol.94
, pp. 1608-1611
-
-
Heptulla, R.A.1
Rodriguez, L.M.2
Mason, K.J.3
Haymond, M.W.4
-
12
-
-
0032976939
-
Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients
-
Toft-Nielsen MB, Madsbad S, Holst JJ. Continuous subcutaneous infusion of glucagon-like peptide 1 lowers plasma glucose and reduces appetite in type 2 diabetic patients. Diabetes Care 1999;22:1137-1143.
-
(1999)
Diabetes Care
, vol.22
, pp. 1137-1143
-
-
Toft-Nielsen, M.B.1
Madsbad, S.2
Holst, J.J.3
-
13
-
-
79959415768
-
Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual beta-cell function
-
Kielgast U, Holst JJ, Madsbad S. Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual beta-cell function. Diabetes. 2011;60:1599-1607.
-
(2011)
Diabetes
, vol.60
, pp. 1599-1607
-
-
Kielgast, U.1
Holst, J.J.2
Madsbad, S.3
-
14
-
-
84866727216
-
Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes
-
Weinzimer SA, Sherr JL, Cengiz E, et al. Effect of pramlintide on prandial glycemic excursions during closed-loop control in adolescents and young adults with type 1 diabetes. Diabetes Care. 2012;35:1994-1999.
-
(2012)
Diabetes Care
, vol.35
, pp. 1994-1999
-
-
Weinzimer, S.A.1
Sherr, J.L.2
Cengiz, E.3
-
15
-
-
78449294264
-
Efficacy and harms of the hypoglycemic agent pramlintide in diabetes mellitus
-
Lee NJ, Norris SL, Thakurta S. Efficacy and harms of the hypoglycemic agent pramlintide in diabetes mellitus. Ann Fam Med. 2010;8:542-549.
-
(2011)
Ann Fam Med
, vol.8
, pp. 542-549
-
-
Lee, N.J.1
Norris, S.L.2
Thakurta, S.3
-
16
-
-
77953199798
-
Safety of pramlintide added to mealtime insulin in patients with type 1 or type 2 diabetes: A large observational study
-
Pencek R, Roddy T, Peters Y, et al. Safety of pramlintide added to mealtime insulin in patients with type 1 or type 2 diabetes: A large observational study. Diabetes Obes Metab. 2010;12: 548-551.
-
(2011)
Diabetes Obes Metab
, vol.12
, pp. 548-551
-
-
Pencek, R.1
Roddy, T.2
Peters, Y.3
-
17
-
-
84869492009
-
Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: Clinical studies and practical approaches to therapy
-
Tobin GS, Cavaghan MK, Hoogwerf BJ, McGill JB. Addition of exenatide twice daily to basal insulin for the treatment of type 2 diabetes: clinical studies and practical approaches to therapy. Int J Clin Pract. 2012;66:1147-1157.
-
(2012)
Int J Clin Pract
, vol.66
, pp. 1147-1157
-
-
Tobin, G.S.1
Cavaghan, M.K.2
Hoogwerf, B.J.3
McGill, J.B.4
-
18
-
-
79959392262
-
Liraglutide as additional treatment for type 1 diabetes
-
Varanasi A, Bellini N, Rawal D, et al. Liraglutide as additional treatment for type 1 diabetes. Eur J Endocrinol. 2011;165: 77-84.
-
(2011)
Eur J Endocrinol
, vol.165
, pp. 77-84
-
-
Varanasi, A.1
Bellini, N.2
Rawal, D.3
-
19
-
-
79551569614
-
Leptin treatment confers clinical benefit at multiple stages of virally induced type 1 diabetes in BB rats
-
Kruger AJ, Yang C, Lipson KL, et al. Leptin treatment confers clinical benefit at multiple stages of virally induced type 1 diabetes in BB rats. Autoimmunity. 2011;44:137-148.
-
(2011)
Autoimmunity
, vol.44
, pp. 137-148
-
-
Kruger, A.J.1
Yang, C.2
Lipson, K.L.3
-
20
-
-
50049108982
-
The accuracy and efficacy of real-Time continuous glucose monitoring sensor in patients with type 1 diabetes
-
Mastrototaro J, Shin J, Marcus A, Sulur G, Investigators SCT. The accuracy and efficacy of real-Time continuous glucose monitoring sensor in patients with type 1 diabetes. Diabetes Technol Ther. 2008;10:385-390.
-
(2008)
Diabetes Technol Ther
, vol.10
, pp. 385-390
-
-
Mastrototaro, J.1
Shin, J.2
Marcus, A.3
Sulur, G.4
Sct, I.5
|